Phase 3 Angina Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Not Yet Recruiting
Phase 3Phase 4
COMparative Pharmacotherapy And peRsonalised stratEgy in the management of Coronary Microvascular Dysfunction double blind randomised controlled Trial - Part 1
Angina with non obstructive coronary artery disease
Sydney Local Health District130 enrolled2 locationsACTRN12625001179426
Not Yet Recruiting
Phase 3Phase 4
COMparative Pharmacotherapy And peRsonalised stratEgy in the management of Coronary Microvascular Dysfunction double blind randomised controlled Trial - Part II
Angina with non obstructive coronary artery disease
Sydney Local Health District130 enrolled2 locationsACTRN12625001174471
Recruiting
Phase 3
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
Chronic Stable Angina Pectoris
Tasly Pharmaceuticals, Inc.765 enrolled1 locationNCT03789552
Recruiting
Phase 2Phase 3
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Angina PectorisMicrovascular AnginaVasospastic Angina+1 more
Stanford University150 enrolled1 locationNCT06424834
Completed
Phase 3
A double blind, randomised placebo controlled trial of topical 2% viscous lignocaine in improving oral intake in children with painful infectious mouth conditions.
gingivostomatitishand, foot and mouth diseaseulcerative pharyngitis+1 more
Sandy (Alexander) M Hopper100 enrolled1 locationACTRN12609000566235
Recruiting
Phase 3
CHAMPION PCI
Myocardial InfarctionAcute Coronary SyndromesUnstable Angina
The Medicines Company9,000 enrolled1 locationACTRN12606000343505